{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:20:19Z","timestamp":1790911219259,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,2,4]]},"DOI":"10.1007\/s40620-018-0517-z","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T23:47:22Z","timestamp":1535586442000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Eculizumab in pregnancy: a narrative overview"],"prefix":"10.1093","volume":"32","author":[{"given":"Laura","family":"Sarno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Maria","family":"Maruotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario M.","family":"Balletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1285-8517","authenticated-orcid":false,"given":"Domenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"517_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(09)60001-5","volume":"373","author":"C Parker","year":"2009","unstructured":"Parker C (2009) Eculizumab for paroxysmal nocturnal hemoglobinuria. Lancet 373:759\u2013767","journal-title":"Lancet"},{"key":"517_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1365-2141.2010.08099.x","volume":"149","author":"R Kelly","year":"2010","unstructured":"Kelly R, Arnold L, Richards S et al (2010) The management of pregnancy in paroxysmal nocturnal hemoglobinuria on long term eculizumab. Br J Hematol 149:446\u2013450. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08099.x","journal-title":"Br J Hematol"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM et al (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117:6786\u20136792. https:\/\/doi.org\/10.1182\/blood-2011-02-333997","journal-title":"Blood"},{"key":"517_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","volume":"220","author":"RF Hallstensen","year":"2015","unstructured":"Hallstensen RF, Bergseth G, Foss S et al (2015) Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology 220:452\u2013459","journal-title":"Immunobiology"},{"key":"517_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/985646","author":"P Palmeira","year":"2012","unstructured":"Palmeira P, Quinello C, Silveira-Lessa AL et al (2012) IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. https:\/\/doi.org\/10.1155\/2012\/985646","journal-title":"Clin Dev Immunol"},{"key":"517_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1442-200x.2000.01245.x","volume":"42","author":"S Hashira","year":"2000","unstructured":"Hashira S, Okitsu-Negishi S, Yoshino K (2000) Placental transfer of IgG subclasses in a Japanese population. Pediatr Int 42:337\u2013342","journal-title":"Pediatr Int"},{"key":"517_CR7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","volume":"373","author":"RJ Kelly","year":"2015","unstructured":"Kelly RJ, H\u00f6chsmann B, Szer J et al (2015) Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 373:1032\u20131039","journal-title":"N Engl J Med"},{"key":"517_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","volume":"73","author":"J Takeda","year":"1993","unstructured":"Takeda J, Miyata T, Kawagoe K et al (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703\u2013711","journal-title":"Cell"},{"key":"517_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/oxfordjournals.jbchem.a021746","volume":"122","author":"T Kinoshita","year":"1997","unstructured":"Kinoshita T, Ohishi K, Takeda J (1997) GPI-anchor synthesis in mammalian cells: genes, their products, and a deficiency. J Biochem 122:251\u2013257","journal-title":"J Biochem"},{"key":"517_CR10","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.leukres.2008.09.008","volume":"33","author":"AV Danilov","year":"2009","unstructured":"Danilov AV, Smith H, Craigo S et al (2009) Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab. Leuk Res 33:2008\u20132009","journal-title":"Leuk Res"},{"key":"517_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.ogx.0000234794.27485.59","volume":"61","author":"S Fieni","year":"2006","unstructured":"Fieni S, Bonfanti L, Gramellini D et al (2006) Clinical management of paroxysmal nocturnal hemoglobinuria in pregnancy: a case report and updated review. Obstet Gynecol Surv 61:593\u2013601","journal-title":"Obstet Gynecol Surv"},{"key":"517_CR12","first-page":"103","volume":"30","author":"J Ray","year":"2000","unstructured":"Ray J, Burows R, Ginsberg J, Burrows E (2000) Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Hemostasis 30:103\u2013117","journal-title":"Hemostasis"},{"key":"517_CR13","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3324\/haematol.2010.037531","volume":"96","author":"S de Guibert","year":"2011","unstructured":"de Guibert S, de Latour RP, Varoqueaux N et al (2011) Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience. Hematologica 96:1276\u20131283","journal-title":"Hematologica"},{"key":"517_CR14","first-page":"36","volume":"4","author":"R Sharma","year":"2015","unstructured":"Sharma R, Keyzner A, Liu J et al (2015) Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis. Leuk Res Rep 4:36\u201338","journal-title":"Leuk Res Rep"},{"key":"517_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ccr3.161","volume":"3","author":"C Patriquin","year":"2015","unstructured":"Patriquin C, Leber B (2015) Increased eculizumab requirements during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: case report and review of the literature. Clin Case Rep 3:88\u201391","journal-title":"Clin Case Rep"},{"key":"517_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/MBC.0000000000000250","volume":"26","author":"G Gessoni","year":"2015","unstructured":"Gessoni G, Canistro R, Bergamini L et al (2015) Postpartum thrombotic complication in a patient with paroxysmal nocturnal hemoglobinuria. Blood Coagul Fibrinolysis 26:458\u2013463","journal-title":"Blood Coagul Fibrinolysis"},{"key":"517_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12185-016-1946-x","volume":"103","author":"N Miyasaka","year":"2016","unstructured":"Miyasaka N, Miura O, Kawaguchi T et al (2016) Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review. Int J Hematol 103:703\u2013712","journal-title":"Int J Hematol"},{"key":"517_CR18","first-page":"1","volume":"2017","author":"A Patel","year":"2017","unstructured":"Patel A, Unnikrishnan A, Murphy M et al (2017) Paroxysmal nocturnal hemoglobinuria in pregnancy: a dilemma in treatment and thromboprophylaxis. Case Rep Hematol 2017:1\u20133","journal-title":"Case Rep Hematol"},{"key":"517_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/MBC.0000000000000248","volume":"26","author":"MC Vekemans","year":"2015","unstructured":"Vekemans MC, Lambert C, Ferrant A et al (2015) Management of pregnancy in paroxysmal nocturnal hemoglobinuria on long-term eculizumab. Blood Coagul Fibrinolysis 26:464\u2013466","journal-title":"Blood Coagul Fibrinolysis"},{"key":"517_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2141.2010.08258.x","volume":"150","author":"R Marasca","year":"2010","unstructured":"Marasca R, Coluccio V, Santachiara R et al (2010) Pregnancy in PNH: another eculizumab baby Kelly. Br J Hematol 150:707\u2013708","journal-title":"Br J Hematol"},{"key":"517_CR21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1681\/ASN.2016090995","volume":"29","author":"M Gaggl","year":"2017","unstructured":"Gaggl M, Aigner C, Csuka D et al (2017) Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome. J Am Soc Nephrol 29:1020\u20131029","journal-title":"J Am Soc Nephrol"},{"key":"517_CR22","first-page":"662","volume":"91","author":"JS Dashe","year":"1998","unstructured":"Dashe JS, Ramin SM, Cunningham FG (1998) The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 91:662\u2013668","journal-title":"Obstet Gynecol"},{"key":"517_CR23","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.2215\/CJN.13121211","volume":"7","author":"F Fakhouri","year":"2012","unstructured":"Fakhouri F, Vercel C, Fr\u00e9meaux-Bacchi V (2012) Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol 7:2100\u20132106","journal-title":"Clin J Am Soc Nephrol"},{"key":"517_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-017-0064-7","volume":"6","author":"G Andries","year":"2017","unstructured":"Andries G, Karass M, Yandrapalli S et al (2017) Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab. Exp Hematol Oncol 6:4. https:\/\/doi.org\/10.1186\/s40164-017-0064-7","journal-title":"Exp Hematol Oncol"},{"key":"517_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000454946","volume":"6","author":"E Demir","year":"2016","unstructured":"Demir E, Yazici H, Ozluk Y et al (2016) Pregnant woman with atypical hemolytic uremic syndrome delivered a healthy newborn under eculizumab treatment. Case Rep Nephrol Dial 6:143\u2013148","journal-title":"Case Rep Nephrol Dial"},{"key":"517_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/AOG.0b013e31828e2612","volume":"122","author":"G Ardissino","year":"2013","unstructured":"Ardissino G, Ossola MW, Baffero GM et al (2013) Eculizumab for atypical hemolytic uremic syndrome in pregnancy. Obstet Gynecol 122:487\u2013489","journal-title":"Obstet Gynecol"},{"key":"517_CR27","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/ndt\/gfw314","volume":"31","author":"A Servais","year":"2016","unstructured":"Servais A, Devillard N, Fr\u00e9meaux-Bacchi V et al (2016) Atypical hemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab. Nephrol Dial Transplant 31:2122\u20132130","journal-title":"Nephrol Dial Transplant"},{"key":"517_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","volume":"34","author":"RM Burwick","year":"2013","unstructured":"Burwick RM, Feinberg BB (2013) Eculizumab for the treatment of preeclampsia\/HELLP syndrome. Placenta 34:201\u2013203","journal-title":"Placenta"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-018-0517-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:03Z","timestamp":1777564563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/1\/17\/8328129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2,4]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0517-z","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they do not have conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Authors of papers that have been cited in the present review have declared that their studies have been approved by the appropriate institutional and\/or national research ethics committee and have been performed in accordance with ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"There is no requirement for an informed consent form, this manuscript being a literature review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}